VYGR — Voyager Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Voyager Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	181	133	119	231	267
Net Total Accounts Receivable
Net Total Receivables	8.11	0.748	0.639	84.5	4.49
Prepaid Expenses
Total Other Current Assets
Total Current Assets	198	137	124	320	277
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	61.5	55.4	33.3	30	47.7
Long Term Investments
Other Long Term Assets
Total Assets	262	194	159	351	393
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	26.8	51	72.6	64.5	49.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	107	98.8	100	115	93.3
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	154	95.1	59	236	300
Total Liabilities & Shareholders' Equity	262	194	159	351	393
Total Common Shares Outstanding